Allergan Inc. (AGN) Financials Nov 20, 2014, 5:29
Post# of 250601
Posted On: 11/20/2014 11:31:00 PM
Allergan Inc. (AGN) Financials Nov 20, 2014, 5:29 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Allergan Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 4.5B 4.92B 5.42B 5.81B 6.29B
Cost of Goods Sold (COGS) incl. D&A 897.2M 860M 876.3M 906.7M 903.5M
COGS excluding D&A 635.1M 602.9M 622.9M 650.1M 648.9M
Depreciation & Amortization Expense 262.1M 257.1M 253.4M 256.6M 254.6M
Depreciation 115.8M 119.1M 125.8M 125.3M 137.9M
Amortization of Intangibles 146.3M 138M 127.6M 131.3M 116.7M
Gross Income 3.61B 4.06B 4.54B 4.9B 5.39B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 2.6B 2.77B 3.09B 3.19B 3.46B
Research & Development 695.9M 761.6M 857.8M 927.1M 1.04B
Other SG&A 1.9B 2.01B 2.24B 2.26B 2.42B
Other Operating Expense 0 0 0 0 (8.6M)
Unusual Expense 86.7M 1.03B 51.4M 98.5M 111.1M
EBIT after Unusual Expense (86.7M) (1.03B) (51.4M) (98.5M) (111.1M)
Non Operating Income/Expense 15M (2.3M) (16.3M) (7.8M) (9.2M)
Non-Operating Interest Income 7M 7.3M 6.9M 6.7M 6.8M
Equity in Affiliates (Pretax) - 0 0 - 0
Interest Expense 92.5M 95.1M 88.1M 78.7M 88.1M
Gross Interest Expense 93.5M 95.6M 89.1M 79.6M 89.9M
Interest Capitalized 1M 500,000 1M 900,000 1.8M
Pretax Income 848.5M 170.8M 1.3B 1.53B 1.73B
Income Tax 224.7M 165.9M 361.6M 430.8M 458.3M
Income Tax - Current Domestic 276.2M 320.7M 340.4M 408.9M 367.1M
Income Tax - Current Foreign 61.3M 94.3M 90.1M 110.2M 152.7M
Income Tax - Deferred Domestic (105.5M) (230.3M) (78M) (88.5M) (47.4M)
Income Tax - Deferred Foreign (7.3M) (18.8M) 9.1M 200,000 (14.1M)
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 623.8M 4.9M 938.1M 1.1B 1.27B
Minority Interest Expense 2.5M 4.3M 3.6M 3.7M 3.6M
Net Income 621.3M 600,000 934.5M 1.1B 1.27B
Extraordinaries & Discontinued Operations 0 0 0 0 (283.8M)
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 (297.9M)
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 14.1M
Net Income After Extraordinaries 621.3M 600,000 934.5M 1.1B 985.1M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 621.3M 600,000 934.5M 1.1B 1.27B
EPS (Basic) 2.05 0.00 3.07 3.64 4.32
Basic Shares Outstanding 303.6M 303.4M 304.4M 301.5M 296.8M
EPS (Diluted) 2.03 0.00 3.01 3.58 4.25
Diluted Shares Outstanding 305.8M 308M 310.2M 307.1M 301.8M
EBITDA 1.27B 1.55B 1.7B 1.97B 2.19B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Allergan Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 4.5B 4.92B 5.42B 5.81B 6.29B
Cost of Goods Sold (COGS) incl. D&A 897.2M 860M 876.3M 906.7M 903.5M
COGS excluding D&A 635.1M 602.9M 622.9M 650.1M 648.9M
Depreciation & Amortization Expense 262.1M 257.1M 253.4M 256.6M 254.6M
Depreciation 115.8M 119.1M 125.8M 125.3M 137.9M
Amortization of Intangibles 146.3M 138M 127.6M 131.3M 116.7M
Gross Income 3.61B 4.06B 4.54B 4.9B 5.39B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 2.6B 2.77B 3.09B 3.19B 3.46B
Research & Development 695.9M 761.6M 857.8M 927.1M 1.04B
Other SG&A 1.9B 2.01B 2.24B 2.26B 2.42B
Other Operating Expense 0 0 0 0 (8.6M)
Unusual Expense 86.7M 1.03B 51.4M 98.5M 111.1M
EBIT after Unusual Expense (86.7M) (1.03B) (51.4M) (98.5M) (111.1M)
Non Operating Income/Expense 15M (2.3M) (16.3M) (7.8M) (9.2M)
Non-Operating Interest Income 7M 7.3M 6.9M 6.7M 6.8M
Equity in Affiliates (Pretax) - 0 0 - 0
Interest Expense 92.5M 95.1M 88.1M 78.7M 88.1M
Gross Interest Expense 93.5M 95.6M 89.1M 79.6M 89.9M
Interest Capitalized 1M 500,000 1M 900,000 1.8M
Pretax Income 848.5M 170.8M 1.3B 1.53B 1.73B
Income Tax 224.7M 165.9M 361.6M 430.8M 458.3M
Income Tax - Current Domestic 276.2M 320.7M 340.4M 408.9M 367.1M
Income Tax - Current Foreign 61.3M 94.3M 90.1M 110.2M 152.7M
Income Tax - Deferred Domestic (105.5M) (230.3M) (78M) (88.5M) (47.4M)
Income Tax - Deferred Foreign (7.3M) (18.8M) 9.1M 200,000 (14.1M)
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 623.8M 4.9M 938.1M 1.1B 1.27B
Minority Interest Expense 2.5M 4.3M 3.6M 3.7M 3.6M
Net Income 621.3M 600,000 934.5M 1.1B 1.27B
Extraordinaries & Discontinued Operations 0 0 0 0 (283.8M)
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 (297.9M)
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 14.1M
Net Income After Extraordinaries 621.3M 600,000 934.5M 1.1B 985.1M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 621.3M 600,000 934.5M 1.1B 1.27B
EPS (Basic) 2.05 0.00 3.07 3.64 4.32
Basic Shares Outstanding 303.6M 303.4M 304.4M 301.5M 296.8M
EPS (Diluted) 2.03 0.00 3.01 3.58 4.25
Diluted Shares Outstanding 305.8M 308M 310.2M 307.1M 301.8M
EBITDA 1.27B 1.55B 1.7B 1.97B 2.19B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)Scroll down for more posts ▼